CASE STUDY — REBRAND
Repositioning a Multiomics Company as a Global Genomics Solutions Leader

The Challenge
MedGenome had built a solid reputation as a product-focused genetic testing company serving lab researchers. But to compete with more established genomics services providers and expand their global footprint, they needed to reposition themselves as a solution-driven partner capable of supporting biopharma innovation end-to-end.
The brand needed to reflect their scientific depth, data advantage, and consultative approach.
Solution
Shift the brand narrative from product provider to full-service solutions partner.

Building credibility with go-to-market messaging tailored for pharma/biotech stakeholders, with an emphasis on partnership and flexibility

Outcome
The refreshed positioning debuted with a soft launch at JPM 2024 and was met with strong reception from industry and investor audiences. The new messaging helped:
- Drive strategic partnerships and high-value collaborations
- Support U.S. market expansion and acquisitions
- Lay the foundation for the 2025 rebrand to Signios Bio, reflecting expanded capabilities and vision
Why it Matters
This work helped transform MedGenome from a transactional testing provider into a trusted innovation partner. This shift elevated their market perception and enabled the business growth that led to their evolution as Signios Bio. It's a prime example of how clear, strategic messaging, when paired with a well-executed digital presence, can unlock next-level traction in complex B2B markets.
Boost your growth with our tailored Services

Website Optimization
Transform your website into a digital hub that establishes credibility and converts.

Messaging Strategy
Translate your science into differentiated strategic messaging that converts.

Lead Generation Systems
Build a predictable pipeline that helps you scale without being overwhelmed.